Antibiotic-chemoattractants enhance neutrophil clearance of Staphylococcus aureus
Open Access
- 25 October 2021
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-15
Abstract
The pathogenStaphylococcus aureuscan readily develop antibiotic resistance and evade the human immune system, which is associated with reduced levels of neutrophil recruitment. Here, we present a class of antibacterial peptides with potential to act both as antibiotics and as neutrophil chemoattractants. The compounds, which we term ‘antibiotic-chemoattractants’, consist of a formylated peptide (known to act as chemoattractant for neutrophil recruitment) that is covalently linked to the antibiotic vancomycin (known to bind to the bacterial cell wall). We use a combination of in vitro assays, cellular assays, infection-on-a-chip and in vivo mouse models to show that the compounds improve the recruitment, engulfment and killing ofS. aureusby neutrophils. Furthermore, optimizing the formyl peptide sequence can enhance neutrophil activity through differential activation of formyl peptide receptors. Thus, we propose antibiotic-chemoattractants as an alternate approach for antibiotic development.Keywords
Funding Information
- Department of Health | National Health and Medical Research Council (APP2003325, APP1140619)
- Department of Education and Training | Australian Research Council (CE200100012)
This publication has 68 references indexed in Scilit:
- V101L of human formyl peptide receptor 1 (FPR1) increases receptor affinity and augments the antagonism mediated by cyclosporinsBiochemical Journal, 2013
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Polymorphisms of the formylpeptide receptor gene (FPR1) and susceptibility to stomach cancer in 1531 consecutive autopsy casesBiochemical and Biophysical Research Communications, 2011
- Formylpeptide Receptor Single Nucleotide Polymorphism 348T>C and Its Relationship to Polymorphonuclear Leukocyte Chemotaxis in Aggressive PeriodontitisJournal of Periodontology, 2009
- International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) FamilyPharmacological Reviews, 2009
- Variable responses of formyl peptide receptor haplotypes toward bacterial peptidesImmunogenetics, 2008
- Differential activation of polymorphisms of the formyl peptide receptor by formyl peptidesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2007
- Imaging peptidoglycan biosynthesis in Bacillus subtilis with fluorescent antibioticsProceedings of the National Academy of Sciences, 2006
- Broad immunocytochemical localization of the formylpeptide receptor in human organs, tissues, and cellsCell and tissue research, 1998
- Formyl-methionyl-leucyl-phenylalanine causes bronchoconstriction in rabbitsInflammation Research, 1986